Company: DAWN
Filing Date: 2025-02-25
Form Type: 10-K
Source: 0000950170-25-026654
Chunk: 279

Company: Day One Biopharmaceuticals, Inc.
Filing Date: 2025-02-25
Form: 10-K
Item: Item 1B
Chunk 279
---

     
    Insider Trading Policy

    X

    21.1
     
    Subsidiaries of the Registrant

    X

129

    23.1
     
    Consent of Pricewaterhouse Coopers LLP, Independent Registered Public Accounting Firm

    X

    23.2
     
    Consent of Ernst & Young LLP, Independent Registered Public Accounting Firm

    X

    31.1
     
    Certification of Principal Executive Officer Pursuant to Rules 13a-14(a) and 15d-14(a) under the Securities Exchange Act of 1934, as Adopted Pursuant to Section 302 of the Sarbanes-Oxley Act of 2002.

    X

    31.2
     
    Certification of Principal Financial Officer Pursuant to Rules 13a-14(a) and 15d-14(a) under the Securities Exchange Act of 1934, as Adopted Pursuant to Section 302 of the Sarbanes-Oxley Act of 2002.

    X

    32.1**
     
    Certification of Principal Executive Officer and Principal Financial Officer Pursuant to 18 U.S.C. Section 1350, as Adopted Pursuant to Section 906 of the Sarbanes-Oxley Act of 2002.

    X

    97.1
     
    Compensation Recovery Policy

    X

    101.INS
     
    Inline XBRL Instance Document

    X

    101.SCH
     
    Inline XBRL Taxonomy Extension Schema Document

    X

    101.CAL
     
    Inline XBRL Taxonomy Extension Calculation Linkbase Document.

    X

    101.DEF
     
    Inline XBRL Taxonomy Extension Definition Linkbase Document.

    X

    101.LAB
     
    Inline XBRL Taxonomy Extension Label Linkbase Document.

    X

    101.PRE  
     
    Inline XBRL Taxonomy Extension Presentation Linkbase Document.

    X

    104
     
    Cover Page Interactive Data File (Embedded within the Inline XBRL document and included in Exhibit 101)

    X

† 	Registrant has omitted portions of the exhibit as permitted under Item 601(b)(10) of Regulations S-K.
^ 	Indicates management contract or compensatory plan.

130

* 	Registrant has omitted schedules and exhibits pursuant to Item 601(a)(5) of Regulation S-K. The Registrant agrees to furnish